The Alzheimer's disease THErapy with NEuroaid (ATHENE) study protocol: Assessing the safety and efficacy of Neuroaid II (MLC901) in patients with mild-to-moderate Alzheimer's disease stable on cholinesterase inhibitors or memantine—A randomized, double-blind, placebo-controlled trial

• Main Authors: Chen, C.L.H., Sharma, P.R., Tan, B.Y., Low, C., Venketasubramanian, N.
• Other Authors: PHARMACOLOGY
• Format: Article
• Published: Elsevier Inc 2021
• Subjects: Alzheimer's disease; Clinical trial; Disease progression; MLC901; Neuroaid II
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/212354
• Institution: National University of Singapore

10.1016/j.trci.2018.12.001